Veriskin
PrivateLast Round
Seed
Nov 10, 2022
Total Funding Raised
$4.15M
Momentum Score
25 /100
Company Overview
Veriskin is a medical device company developing TruScore, a non-invasive, handheld device that uses AI and hemodynamic measurements for the rapid diagnosis of skin cancer.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Devices, Sensors
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Veriskin Comps
Public and private peers based on sector, stage, and business model.
Veriskin Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 10, 2022 | ||||
| Grant | Jul 14, 2022 | ||||
| Grant | Sep 22, 2021 |
Veriskin Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Arizona Tech Investors | Seed |
| NIH RADx | Grant |
| Pasadena Angels Funds I and II | Seed |
| Frontier Angels | Seed |
| Ariel Savannah Angel Partners | Seed |
| TiE SoCal Angels | Seed |
Veriskin Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Veriskin's valuation, stock price, and market status.
